42 related articles for article (PubMed ID: 33819418)
1. Successful treatment approaches for tumoral calcinosis in children and young people: A condition of diverse pathogenesis.
Anilkumar A; Högler W; Bursell J; Nadar R; Ryan F; Randell T; Shaw NJ; Uday S
Bone; 2024 May; 182():117049. PubMed ID: 38364881
[TBL] [Abstract][Full Text] [Related]
2. Novel genetic mutation associated with hyperphosphatemic familial tumoral calcinosis/hyperostosis-hyperphosphatemia syndrome treated with denosumab: a case report.
Fabbriciani G; Colombini A; Messina C; Adami G
Reumatismo; 2024 Jun; 76(2):. PubMed ID: 38916164
[TBL] [Abstract][Full Text] [Related]
3. A Sole Case of the FGF23 Gene Mutation c.202A>G (p.Thr68Ala) Associated with Multiple Severe Vascular Aneurysms and a Hyperphosphatemic Variant of Tumoral Calcinosis-A Case Report.
Ivanova NG
Life (Basel); 2024 May; 14(5):. PubMed ID: 38792634
[TBL] [Abstract][Full Text] [Related]
4. Clinical Characteristics, Therapeutic Options, and Outcomes in Hyperphosphatemic Tumoral Calcinosis: A Systematic Review.
Cherian KE; Cherian J; Vinodhini D; Paul TV
Calcif Tissue Int; 2024 Jul; ():. PubMed ID: 38951179
[TBL] [Abstract][Full Text] [Related]
5. Recalcitrant digital calcinosis cutis successfully treated with intralesional sodium thiosulfate under digital nerve blockade.
Le Q; Robinson A; Stevens W; Li J
BMJ Case Rep; 2022 Apr; 15(4):. PubMed ID: 35387792
[TBL] [Abstract][Full Text] [Related]
6. Relationship between rs7586085, GALNT3 and CCDC170 gene polymorphisms and the risk of osteoporosis among the Chinese Han population.
Zhang J; Cai Q; Chen W; Huang M; Guan R; Jin T
Sci Rep; 2022 Apr; 12(1):6089. PubMed ID: 35414641
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of hyperphosphatemia with sevelamer hydrochloride in CKD patients: effects on vascular calcification and mortality].
Koizumi M; Fukagawa M
Clin Calcium; 2010 Nov; 20(11):1700-8. PubMed ID: 21037391
[TBL] [Abstract][Full Text] [Related]
8. Hyperphosphatemic Tumoral Calcinosis: Pathogenesis, Clinical Presentation, and Challenges in Management.
Boyce AM; Lee AE; Roszko KL; Gafni RI
Front Endocrinol (Lausanne); 2020; 11():293. PubMed ID: 32457699
[TBL] [Abstract][Full Text] [Related]
9. Hyperphosphatemic familial tumoral calcinosis: response to acetazolamide and postulated mechanisms.
Finer G; Price HE; Shore RM; White KE; Langman CB
Am J Med Genet A; 2014 Jun; 164A(6):1545-9. PubMed ID: 24668887
[TBL] [Abstract][Full Text] [Related]
10. Topical Sodium Thiosulfate: A Treatment for Calcifications in Hyperphosphatemic Familial Tumoral Calcinosis?
Jost J; Bahans C; Courbebaisse M; Tran TA; Linglart A; Benistan K; Lienhardt A; Mutar H; Pfender E; Ratsimbazafy V; Guigonis V
J Clin Endocrinol Metab; 2016 Jul; 101(7):2810-5. PubMed ID: 27163355
[TBL] [Abstract][Full Text] [Related]
11. The Successful Treatment of Deep Soft-tissue Calcifications with Topical Sodium Thiosulphate and Acetazolamide in a Boy with Hyperphosphatemic Familial Tumoral Calcinosis due to a Novel Mutation in
Döneray H; Özden A; Gürbüz K
J Clin Res Pediatr Endocrinol; 2022 Jun; 14(2):239-243. PubMed ID: 33685073
[TBL] [Abstract][Full Text] [Related]
12. Familial tumoral calcinosis caused by a novel FGF23 mutation: response to induction of tubular renal acidosis with acetazolamide and the non-calcium phosphate binder sevelamer.
Lammoglia JJ; Mericq V
Horm Res; 2009; 71(3):178-84. PubMed ID: 19188744
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic success of sodium thiosulfate in treating cutaneous calciphylaxis in a patient with hyperphosphataemic familial tumoral calcinosis.
Requena S; Santos-Juanes J; Morales P; Gómez C
Australas J Dermatol; 2022 Feb; 63(1):e75-e77. PubMed ID: 34817065
[TBL] [Abstract][Full Text] [Related]
14. Familial hyperphosphatemic tumoral calcinosis in an unusual and usual sites and dramatic improvement with the treatment of acetazolamide, sevelamer and topical sodium thiosulfate.
Emecen Sanli M; Kilic A; Aktasoglu E; Inci A; Okur I; Ezgu F; Tumer L
J Pediatr Endocrinol Metab; 2021 Jun; 34(6):813-816. PubMed ID: 33819418
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
